feed,title,long_url,short_url
Benzinga,"The Global Chronic Myelogenous Leukemia Therapeutics Market is expected to grow by $ 2.14 bn during 2022-2026, accelerating at a CAGR of 6.1% during the forecast period",https://benzinga.com/pressreleases/22/09/g28910527/the-global-chronic-myelogenous-leukemia-therapeutics-market-is-expected-to-grow-by-2-14-bn-during-,
